Dr. Kaeberlein Speaks at CTGN’s 2nd Scientific Meeting

Our CEO, Dr. Matt Kaeberlein, will be speaking at the Canadian Translational Geroscience Network’s 2nd Scientific Meeting of the Canadian Translational Geroscience Network!
Matt’s talk will be focused on The Dog Aging Project, specifically speaking about Companion Animals as a Catalyst toward Human Longevity Therapeutics
The event is on October 16th and 17th, and you can register from now until October 16th at the link below!

Register Here:
https://event.fourwaves.com/geroscience/pages

Next
Next

Business Insights Journal Interview with Dr. Matt Kaeberlein CEO of Optispan